patent for semaglutide Expiry to Boost GCC Diabetes and Obesity Treatment | Ata Ul Haque posted on the topic Semaglutide patent expiry in India

Key stat: 63% of millennials and 61% of Gen Zers feel more connected to health brands since starting GLP-1s, per a January Dentsu report

Hormone Res 52:73-79, 1999

muciniphila and diseases, such as inflammatory bowel diseases (IBD), obesity and type 2 diabetes and its related cardiometabolic disorders, and other inflammatory or auto-immune diseases, such as asthma and type 1 diabetes [5-13]

However, the melanocortin-1 receptor (MC1R) activation it triggers continues driving melanin synthesis for days to weeks after clearance, sustaining cosmetic tanning effects far beyond the compound's presence in circulation

Loud noises and strong smells, like perfume or cleaning products, are also common triggers